Cytek Biosciences, Inc. (CTKB)
5.59
+0.16
(+2.95%)
USD |
NASDAQ |
Oct 23, 16:00
5.59
0.00 (0.00%)
After-Hours: 20:00
Cytek Biosciences Price : 5.59 for Oct. 23, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 23, 2026 | 5.38 | 5.64 | 5.30 | 5.59 | 704855.0 |
| Oct 22, 2026 | 5.53 | 5.66 | 5.35 | 5.43 | 694301.0 |
| Oct 21, 2026 | 5.26 | 5.545 | 5.24 | 5.50 | 1.093M |
| Oct 20, 2026 | 5.29 | 5.49 | 5.26 | 5.34 | 805962.0 |
| Oct 19, 2026 | 5.27 | 5.34 | 5.19 | 5.25 | 700551.0 |
| Oct 16, 2026 | 5.41 | 5.41 | 5.205 | 5.25 | 1.045M |
| Oct 15, 2026 | 5.36 | 5.48 | 5.29 | 5.41 | 905398.0 |
| Oct 14, 2026 | 5.25 | 5.475 | 5.23 | 5.395 | 1.075M |
| Oct 13, 2026 | 5.19 | 5.465 | 5.18 | 5.35 | 1.426M |
| Oct 12, 2026 | 5.42 | 5.42 | 5.115 | 5.31 | 1.037M |
| Oct 09, 2026 | 5.32 | 5.555 | 5.30 | 5.43 | 3.884M |
| Oct 08, 2026 | 5.26 | 5.38 | 5.045 | 5.36 | 1.712M |
| Oct 07, 2026 | 5.21 | 5.34 | 5.110 | 5.34 | 1.783M |
| Oct 06, 2026 | 6.13 | 6.21 | 5.355 | 5.38 | 2.052M |
| Oct 05, 2026 | 5.88 | 6.105 | 5.825 | 6.09 | 1.788M |
| Oct 02, 2026 | 5.86 | 5.94 | 5.75 | 5.87 | 1.099M |
| Oct 01, 2026 | 5.96 | 5.97 | 5.750 | 5.81 | 1.572M |
| Sep 30, 2026 | 5.76 | 5.985 | 5.67 | 5.96 | 1.324M |
| Sep 29, 2026 | 5.74 | 5.855 | 5.655 | 5.76 | 869963.0 |
| Sep 28, 2026 | 5.62 | 5.78 | 5.53 | 5.74 | 1.086M |
| Sep 25, 2026 | 5.71 | 5.75 | 5.57 | 5.65 | 1.495M |
| Sep 24, 2026 | 5.64 | 5.83 | 5.48 | 5.73 | 1.595M |
| Sep 23, 2026 | 5.73 | 5.85 | 5.63 | 5.68 | 1.261M |
| Sep 22, 2026 | 5.29 | 5.84 | 5.26 | 5.71 | 3.779M |
| Sep 21, 2026 | 5.32 | 5.32 | 5.20 | 5.28 | 1.255M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Agilent Technologies, Inc. | 173.07 |
| Bio-Rad Laboratories, Inc. | 369.95 |
| Bruker Corp. | 57.59 |
| Danaher Corp. | 230.50 |
| Harvard Bioscience, Inc. | 8.23 |
Price Related Metrics
| PS Ratio | 3.474 |
| PEG Ratio | -0.0079 |
| Price to Book Value | 2.257 |
| Earnings Yield | -11.22% |
| Market Cap | 726.60M |
| PEGY Ratio | -0.0079 |